My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Sanidad Militar
Print version ISSN 1887-8571
Abstract
SANCHEZ JIMENEZ, FJ; LOPEZ HONDUVILLA, FJ; APARICIO HERNANDEZ, R and GARCIA LUQUE, A. Possitive assessment of drugs: june/july 2017. Sanid. Mil. [online]. 2017, vol.73, n.4, pp.226-230. ISSN 1887-8571. https://dx.doi.org/10.4321/s1887-85712017000400005.
The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in, June1 and July 20172, considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.
Keywords : Adalimumab (Imraldi®); Atezolizumab (Tecentriq®); Avelumab (Bavencio®); Ciclosporina (Verkazia®); Cladribina (Mavenclad®): Darunavir/Cobicistat/Emtricitabina/ Tenofovir Alafenamida (Symtuza®); Dupilumab (Dupixent®); Glecaprevir/Pibrentasvir (Maviret®): Lutecio (177lu) Oxodotreotido (Lutathera®); Midostaurina (Rydapt®); Ribociclib (Kisqal®); Sofosbuvir/Velpatasvir/ Voxilaprevir (Vosevi®); Telotristat de Etilo (Xermelo®); Tivozanib Hidrocloruro Monohidrato (Fotivda®).